Zobrazeno 1 - 10
of 32
pro vyhledávání: '"G C, Actis"'
Autor:
G. C., Actis1 Actis_g@libero.it
Publikováno v:
Progress in Health Sciences. Dec2016, Vol. 6 Issue 2, p165-174. 10p.
Publikováno v:
Minerva gastroenterologica e dietologica. 60(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bc9e875d41e558a6087b7bf24245b7e2
https://pubmed.ncbi.nlm.nih.gov/25176055
https://pubmed.ncbi.nlm.nih.gov/25176055
Autor:
G C, Actis, F, Rosina
Publikováno v:
Minerva gastroenterologica e dietologica. 56(1)
This was a retrospective survey of 88 inflammatory bowel disease patients (43 with ulcerative colitis, 38 with Crohn's disease, 7 with indeterminate colitis) who were visited between January 2008 and June 2009 at a newly established out-patient servi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d909655b3ee018420da5a1357e361808
https://pubmed.ncbi.nlm.nih.gov/20190722
https://pubmed.ncbi.nlm.nih.gov/20190722
Publikováno v:
Minerva gastroenterologica e dietologica. 54(3)
Third-level Day-Hospital Services of Gastro-Hepatology are likely to recruit patients with an increased disease severity. The burden of request for immunomodulation drugs is presently unclear.The charts of 1 012 consecutive patients who underwent day
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::323ce4b46268431b471bf4dd97367c4c
https://pubmed.ncbi.nlm.nih.gov/18614972
https://pubmed.ncbi.nlm.nih.gov/18614972
Publikováno v:
Minerva gastroenterologica e dietologica. 53(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::511064525a4cab9c43ea97768c599543
https://pubmed.ncbi.nlm.nih.gov/17912185
https://pubmed.ncbi.nlm.nih.gov/17912185
Autor:
G C, Actis, M, Pinna-Pintor
Publikováno v:
Minerva gastroenterologica e dietologica. 48(2)
Ulcerative colitis is a chronic inflammatory disease of the colon thought to be caused by an abnormal T-cell response to lumenal antigens. In the last 10 years immunosuppressives have been proposed to treat its severe forms including cyclosporin and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::00acc4d895acabe44b9a1d5066658f47
https://pubmed.ncbi.nlm.nih.gov/16489302
https://pubmed.ncbi.nlm.nih.gov/16489302
Publikováno v:
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 36(6)
The monoclonal antibody to the tumour necrosis factor--infliximab--has recently been added to the list of off-label therapeutic means for ulcerative colitis. We conducted a descriptive analysis of the results from studies on the use of the drug publi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ddbdb8b303e4f85705694a15732cdaa8
https://pubmed.ncbi.nlm.nih.gov/15248385
https://pubmed.ncbi.nlm.nih.gov/15248385
Publikováno v:
Alimentary pharmacologytherapeutics. 15(9)
It has been shown that azathioprine prolongs the response to ciclosporin of steroid-refractory ulcerative colitis, but no specific data are available concerning its toxicity in this indication.The charts of 21 patients with steroid-refractory ulcerat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7f5cc050c0ee9fd32d1b146b235e1810
https://pubmed.ncbi.nlm.nih.gov/11552900
https://pubmed.ncbi.nlm.nih.gov/11552900
Publikováno v:
Panminerva medica. 42(4)
The resectability rate of hilar bile duct carcinoma is reported to be variable and to inversely correlate with the size of the associated liver resection. In an attempt to reduce the risk of postoperative liver failure, the induction of a hypertrophy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::48121a500adba084a6e7d299ce23813e
https://pubmed.ncbi.nlm.nih.gov/11294093
https://pubmed.ncbi.nlm.nih.gov/11294093
Autor:
T, Gindro, A, Arrigoni, G, Martinasso, F, Rosina, S, Perardi, N, Cappello, P, Benedetti, G C, Actis, G, Verme, M, Rizzetto
Publikováno v:
European journal of gastroenterologyhepatology. 9(12)
To evaluate the clinical and prognostic value of the monoethyl glycine xylidide (MEGX) test in patients with primary biliary cirrhosis (PBC) in comparison with the Mayo score (Mayo).A prospective study.MEGX determinations at enrolment were compared t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7f4ecc6c726c2dd4aebac76c525a8369
https://pubmed.ncbi.nlm.nih.gov/9471018
https://pubmed.ncbi.nlm.nih.gov/9471018